δ-Catenin peptide vaccines repress hepatocellular carcinoma growth via CD8(+) T cell activation

As classical therapy method of advanced hepatocellular carcinoma (HCC) is not effective enough, HCC immunotherapy is a hot spot for research in recent years. Although in recent years, immune checkpoint inhibitors are focused in cancer therapy, vaccines and adoptive cell therapy (ACT), as traditional...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Huang, Fei, Chen, Junying, Lan, Ruilong, Wang, Zeng, Chen, Ruiqing, Lin, Jingan, Zhang, Lurong, Fu, Lengxi
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6136873/
https://ncbi.nlm.nih.gov/pubmed/30221043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1450713
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados